Targeting Wnt5A and SRC1 in prostate cancer with siRNA. Targeting Wnt5A and SRC1 in prostate cancer with siRNA
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
We investigated the role of Wnt5A and SRC1 in castration-resistant prostate cancer cells using corresponding siRNA. Overall design: LNCaP-abl (Abl) cells were transfected with siRNA against Wnt5A or SRC1 or non-targeting control (siNT). RNA was extracted 72h post-transfection.
创建时间：
2020-03-19
